跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,931 条关于
“LRRK2 kinase”
全部
3,931
临床试验
1,764
药物
469
机构
17
资讯
1,681
去年
Oncodesign Precision Medicine Reacquires OPM-201 Rights from Servier After Positive Phase I Trial
3个月前
Genetics of Parkinson Disease: Paradigm Shifts and Future Prospects
去年
Neuron23 Secures $96.5M Series D Funding as First Patient Dosed in Phase 2 Parkinson's Disease Trial
去年
Neuron23 Advances Precision Medicine in Parkinson's Disease with Digital Biomarker-Driven Phase 2 Trial
去年
Advancements in Parkinson's Disease Therapy: A Review of Current Strategies and Future Research Priorities
去年
Denali Therapeutics Initiates Phase 2a Trial of BIIB122 for LRRK2-Associated Parkinson's Disease
去年
Halia Therapeutics Presents LRRK2 Inhibitor HT-4253 for Neurodegenerative Diseases at BIO Investor Forum
5个月前
Biognosys Partners with Michael J. Fox Foundation to Develop Critical LRRK2 Biomarker Assays for Parkinson's Disease
去年
Montara Therapeutics Receives $3.3M Grant from Michael J. Fox Foundation to Develop Brain-Selective LRRK2 Inhibitor for Parkinson's
去年
Arvinas' ARV-102 Shows Promising Brain Penetration and LRRK2 Reduction in First-in-Human Parkinson's Trial
第 1 页,共 169 页
上一页
下一页